| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |